HuGE Literature Finder
Records
1
-
30
| A nuclear polymorphism at the 8q24 region is associated with improved survival time and chemo-response in high-grade serous ovarian cancer. Oncology letters 2021 Oct 22 (4): 733. Ikoma Danielle, Cardillo Nicholas, Devor Eric, Gonzalez-Bosquet Jes |
| Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination. NPJ breast cancer 2021 Oct 7 (1): 135. Setton Jeremy, Selenica Pier, Mukherjee Semanti, Shah Rachna, Pecorari Isabella, McMillan Biko, Pei Isaac X, Kemel Yelena, Ceyhan-Birsoy Ozge, Sheehan Margaret, Tkachuk Kaitlyn, Brown David N, Zhang Liying, Cadoo Karen, Powell Simon, Weigelt Britta, Robson Mark, Riaz Nadeem, Offit Kenneth, Reis-Filho Jorge S, Mandelker Dia |
| Identification and clinical significance of somatic oncogenic mutations in epithelial ovarian cancer. Journal of ovarian research 2021 Oct 14 (1): 129. Watanabe Takafumi, Nanamiya Hideaki, Endo Yuta, Kojima Manabu, Nomura Shinji, Furukawa Shigenori, Soeda Shu, Tamura Hirosumi, Ryufuku Masae, Tanaka Daisuke, Isogai Takao, Imai Jun-Ichi, Watanabe Shinya, Fujimori Kei |
| Association of IL-6 -174G>C and -572G>C Polymorphisms with Susceptibility to Cervical Cancer and Ovarian Cancer. Asian Pacific journal of cancer prevention : APJCP 2021 Sep 22 (9): 2867-2871. Hashemzehi Ahmad, Karimi-Zarchi Mojgan, Parsaeian Seyedeh Fatemeh, Asadian Fatemeh, Golestanpour Hossein, Setayesh Sepideh, Shaker Seyed Amir, Zare-Shehneh Masoud, Neamatzadeh Hosse |
| Dominant-negative pathogenic variant BRIP1 c.1045G>C is a high-risk allele for non-mucinous epithelial ovarian cancer: A case-control study. Clinical genetics 2021 Sep . Flaum Nicola, van Veen Elke M, Smith Olivia, Amico Stephanie, Newman William G, Crosbie Emma J, Edmondson Richard, Smith Miriam J, Evans D Gare |
| PARP inhibitors decrease response to subsequent platinum-based chemotherapy in patients with BRCA mutated ovarian cancer. Anti-cancer drugs 2021 Sep . Rose Peter G, Yao Meng, Chambers Laura M, Mahdi Haider, DeBernardo Robert, Michener Chad M, AlHilli Miriam, Ricci Stephanie, Vargas Rober |
| Phase 1b dose expansion and translational analyses of olaparib in combination with capivasertib in recurrent endometrial, triple negative breast, and ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 Sep . Westin Shannon N, Labrie Marilyne, Litton Jennifer K, Blucher Aurora, Fang Yong, Vellano Christopher P, Marszalek Joseph R, Feng Ningping, Ma Xiaoyan, Creason Allison, Fellman Bryan, Yuan Ying, Lee Sanghoon, Kim TaeBeom, Liu Jinsong, Chelariu-Raicu Anca, Chen Tsun Hsuan, Kabil Nashwa, Soliman Pamela T, Frumovitz Michael, Schmeler Kathleen M, Jazaeri Amir, Lu Karen H, Murthy Rashmi, Meyer Larissa, Sun Charlotte, Sood Anil K, Coleman Robert L, Mills Gordon |
| Bilateral salpingo-oophorectomy and breast cancer risk for BRCA1 and BRCA2 mutation carriers: Assessing the evidence. Cancer prevention research (Philadelphia, Pa.) 2021 Aug . Conduit Ciara, Milne Roger L, Friedlander Michael L, Phillips Kelly-An |
| Venous thromboembolism incidence in cancer patients with germline BRCA mutations. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 Aug . Muñoz A J, de Toro M, Ortega L, López C, Gutiérrez A, Juliao D S, Arregui M, Lobato N, Echavarría I, Márquez-Rodas I, Martín |
| Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2021 Aug . Kim Shana J, Lubi?ski Jan, Huzarski Tomasz, Møller Pål, Armel Susan, Karlan Beth Y, Senter Leigha, Eisen Andrea, Foulkes William D, Singer Christian F, Tung Nadine, Bordeleau Louise, Neuhausen Susan L, Olopade Olufunmilayo I, Eng Charis, Weitzel Jeffrey N, Fruscio Robert, Narod Steven A, Kotsopoulos Joan |
| ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer. Gynecologic oncology 2021 Jul . Kuroda Yuka, Chiyoda Tatsuyuki, Kawaida Miho, Nakamura Kohei, Aimono Eriko, Yoshimura Takuma, Takahashi Mio, Saotome Keiko, Yoshihama Tomoko, Iwasa Naomi, Sakai Kensuke, Yamagami Wataru, Nishihara Hiroshi, Aoki Daisu |
| Association of somatic mutations in BRCA2 BRC domain with chemotherapy sensitivity and survival in high grade serous ovarian cancer. Experimental cell research 2021 Jul 406 (1): 112742. Zhang Guonan, Zhang Jie, Zhu Yi, Liu Hong, Shi Yu, Mi Kun, Li Meiying, Zhao Qi, Huang Ziyi, Huang Jianmi |
| Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions. International journal of molecular sciences 2021 Jul 22 (14): . Guglielmi Chiara, Scarpitta Rosa, Gambino Gaetana, Conti Eleonora, Bellè Francesca, Tancredi Mariella, Cervelli Tiziana, Falaschi Elisabetta, Cosini Cinzia, Aretini Paolo, Congregati Caterina, Marino Marco, Patruno Margherita, Pilato Brunella, Spina Francesca, Balestrino Luisa, Tenedini Elena, Carnevali Ileana, Cortesi Laura, Tagliafico Enrico, Tibiletti Maria Grazia, Tommasi Stefania, Ghilli Matteo, Vivanet Caterina, Galli Alvaro, Caligo Maria Adelai |
| A novel BRCA1 duplication and new insights on the spectrum and frequency of germline large genomic rearrangements in BRCA1/BRCA2. Molecular biology reports 2021 Jun . Sahin Ibrahim, Saat Hani |
| Association between RAD51, XRCC2 and XRCC3 gene polymorphisms and risk of ovarian cancer: a case control and an in silico study. Molecular biology reports 2021 Jun . Gowtham Kumar G, Paul Solomon Franklin Durairaj, Martin Jovita, Manickavasagam M, Sundersingh Shirley, Ganesan Nalini, Ramya R, Usha Rani G, Andrea Mary Franc |
| Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study. Gynecologic oncology 2021 Jun . Safra Tamar, Waissengrin Barliz, Gerber Deanna, Bernstein-Molho Rinat, Klorin Geula, Salman Lina, Josephy Dana, Chen-Shtoyerman Rakefet, Bruchim Ilan, Frey Melissa K, Pothuri Bhavana, Muggia Fran |
| Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer. Genetics in medicine : official journal of the American College of Medical Genetics 2021 Jun . Woodward Emma R, van Veen Elke M, Forde Claire, Harkness Elaine F, Byers Helen J, Ellingford Jamie M, Burghel George J, Schlech Helene, Bowers Naomi L, Wallace Andrew J, Howell Sacha J, Howell Anthony, Lalloo Fiona, Newman William G, Smith Miriam J, Gareth Evans |
| ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis. Journal of ovarian research 2021 Jun 14 (1): 80. Zhang Yuqiang, Cao Sufen, Zhuang Chunyu, Chen Jiacheng, Chen Xiaojing, Sun Hong, Lin Shengying, Lin Baila |
| Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients. Cancer chemotherapy and pharmacology 2021 Jun . Sokolenko Anna P, Gorodnova Tatiana V, Bizin Ilya V, Kuligina Ekaterina Sh, Kotiv Khristina B, Romanko Alexandr A, Ermachenkova Tatiana I, Ivantsov Alexandr O, Preobrazhenskaya Elena V, Sokolova Tatiana N, Broyde Robert V, Imyanitov Evgeny |
| Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study. JCO global oncology 2021 Jun 7 849-861. Gupta Sudeep, Rajappa Senthil, Advani Suresh, Agarwal Amit, Aggarwal Shyam, Goswami Chanchal, Palanki Satya Dattatreya, Arya Devavrat, Patil Shekhar, Kodagali Roh |
| Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer. Journal of personalized medicine 2021 Jun 11 (7): . Bekos Christine, Grimm Christoph, Kranawetter Marlene, Polterauer Stephan, Oberndorfer Felicitas, Tan Yen, Müllauer Leonhard, Singer Christian |
| NLR and BRCA mutational status in patients with high grade serous advanced ovarian cancer. Scientific reports 2021 May 11 (1): 11125. Marchetti Claudia, D'Indinosante Marco, Bottoni Carolina, Di Ilio Chiara, Di Berardino Stefano, Costantini Barbara, Minucci Angelo, Vertechy Laura, Scambia Giovanni, Fagotti An |
| Prostate cancer risk variants of the HOXB genetic locus. Scientific reports 2021 May 11 (1): 11385. Dupont William D, Breyer Joan P, Johnson Spenser H, Plummer W Dale, Smith Jeffrey |
| Association of FSHR gene polymorphisms with endometriosis in women visiting tertiary-care hospitals of Lahore, Pakistan. JPMA. The Journal of the Pakistan Medical Association 2021 Apr 71 (4): 1118-1122. Liaqat Irfana, Arifa Najiya Al, Asif Saba, Lone Khalid Parva |
| Assessment of Significant Pathway Signaling and Prognostic Value of GNG11 in Ovarian Serous Cystadenocarcinoma. International journal of general medicine 2021 14 2329-2341. Jiang Ming-Min, Zhao Fan, Lou Tao-T |
| Beyond BRCA Status: Clinical Biomarkers May Predict Therapeutic Effects of Olaparib in Platinum-Sensitive Ovarian Cancer Recurrence. Frontiers in oncology 2021 11 697952. Nakanishi Kazuho, Yamada Takashi, Ishikawa Gen, Suzuki Shun |
| Identification of Eleven Novel Frontiers in oncology 2021 11 674965. Hamdi Yosr, Mighri Najah, Boujemaa Maroua, Mejri Nesrine, Ben Nasr Sonia, Ben Rekaya Mariem, Messaoud Olfa, Bouaziz Hanen, Berrazega Yosra, Rachdi Haifa, Jaidane Olfa, Daoud Nouha, Zribi Aref, Ayari Jihene, El Benna Houda, Labidi Soumaya, Ben Hassouna Jamel, Haddaoui Abderazzek, Rahal Khaled, Benna Farouk, Mrad Ridha, Ben Ahmed Slim, Boussen Hamouda, Boubaker Samir, Abdelhak Son |
| Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer. BioMed research international 2021 2021 6622439. Liu Shaoqiu, He Lewei, Sheng Chenchen, Su Rongjia, Wu Xiaomei, Sun Yunyan, Xi Xiaow |
| Spectrum of JCO precision oncology 2021 5 . Chui M Herman, Chang Jason C, Zhang Yanming, Zehir Ahmet, Schram Alison M, Konner Jason, Drilon Alexander E, Da Cruz Paula Arnaud, Weigelt Britta, Grisham Rachel |
| The ovarian carcinoma risk with the polymorphisms of CYP1B1 come from the positive selection. American journal of translational research 2021 13 (5): 4322-4341. Zhang Liying, Feng Liyuan, Lou Meng, Deng Xihan, Liu Chuanzhong, Li |
- Page last reviewed:Oct 1, 2021
- Page last updated:Oct 28, 2021
- Content source: